Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 351 - 375 of 2,711

«
1
…
13
14
15
16
17
…
109
»

The Role of Immunotherapy in Breast Cancer

The Role of Immunotherapy in Breast Cancer

By: Richard S. Finn, MD

CDK4-6 and PIK3CA Inhibitors in Breast Cancer Management

CDK4-6 and PIK3CA Inhibitors in Breast Cancer Management

By: Richard S. Finn, MD

Updates in Metastatic Breast Cancer: Top News

Updates in Metastatic Breast Cancer: Top News

By: Sandra Franco, MD

Updates in Metastatic Breast Cancer: Top News

Updates in Metastatic Breast Cancer: Top News

By: Sandra Franco, MD

New Approaches in the Managment of HER2+ Breast Cancers

New Approaches in the Managment of HER2+ Breast Cancers

By: Sara A. Hurtvitz, MD

HER-2 Disease - Neo-, Adjuvant, Metastatic settings

HER-2 Disease - Neo-, Adjuvant, Metastatic settings

By: Shanu Modi, MD

ER Positive Breast Cancer Updates in 2024

ER Positive Breast Cancer Updates in 2024

By: Sonya Reid, MD MPH

Inhibiting CDK4/6, PIK3CA, and PARP in mBC

Inhibiting CDK4/6, PIK3CA, and PARP in mBC

By: Stephanie Graff, MD

Breast Cancer Update in Triple Negative and HER2 Breast Cancers

Breast Cancer Update in Triple Negative and HER2 Breast Cancers

By: Stephanie L. Graff, MD

Breast Cancer Update in Triple Negative and HER2 Breast Cancers

Breast Cancer Update in Triple Negative and HER2 Breast Cancers

By: Stephanie L. Graff, MD

CDK4/6, PIK3CA & PARP Inhibitors in MBCA

CDK4/6, PIK3CA & PARP Inhibitors in MBCA

By: Stephanie L. Graff, MD

CDK4/6, PIK3CA & PARP Inhibitors in MBCA

CDK4/6, PIK3CA & PARP Inhibitors in MBCA

By: Stephanie L. Graff, MD

Case Presentation - Breast

Case Presentation - Breast

By: Sukhmani K Gill, MD

Case Presentation - Breast

Case Presentation - Breast

By: Sukhmani K Gill, MD

Estrogen Receptor Positive Breast Cancer The Interplay Between Biology and the Logic of Treatment

Estrogen Receptor Positive Breast Cancer The Interplay Between Biology and the Logic of Treatment

By: Suleiman A. Massarweh, MD

New Biomarkers in Breast Cancer

New Biomarkers in Breast Cancer

By: Tanya Gupta, MD

New Biomarkers in Breast Cancer

New Biomarkers in Breast Cancer

By: Tanya Gupta, MD

Current Practice and Future Developments in HR+ Breast Cancer

Current Practice and Future Developments in HR+ Breast Cancer

By: V.K. Gadi, MD, PhD

ER/PR Breast Disease: Early Stage- Locally Advanced and Metastatic Breast Cancer

ER/PR Breast Disease: Early Stage- Locally Advanced and Metastatic Breast Cancer

By: Vicente Valero - MD - FACP

Hormonal Management of Metastatic Breast Cancer

Hormonal Management of Metastatic Breast Cancer

By: Vicente Valero, M.D

ER/PR+ Metastatic Breast Cancer

ER/PR+ Metastatic Breast Cancer

By: Vicente Valero, MD

Endocrine Therapy in the Neoadjuvant and Adjuvant Setting: ER+ HER-2 Normal Node Negative and Node Positive Breast Cancer

Endocrine Therapy in the Neoadjuvant and Adjuvant Setting: ER+ HER-2 Normal Node Negative and Node Positive Breast Cancer

By: Vicente Valero, MD

Endocrine Therapy in the Neoadjuvant & Adjuvant Setting

Endocrine Therapy in the Neoadjuvant & Adjuvant Setting

By: Vicente Valero, MD

Endocrine Therapy in the Neoadjuvant & Adjuvant Setting

Endocrine Therapy in the Neoadjuvant & Adjuvant Setting

By: Vicente Valero, MD

Targeted Therapy in Breast Cancer Beyond ER/PR

Targeted Therapy in Breast Cancer Beyond ER/PR

By: Vicente Valero, MD

«
1
…
13
14
15
16
17
…
109
»

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok